- Global Pharma News & Resources

Notice of Interim Results

LONDON, U.K AND DALLAS, TX, U.S Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for faster and more accurate treatment decisions in wound care, announces that its interim results for the six month period ended 30 June 2021 will be released on Monday, 13 September 2021.

Investor presentation

Wensheng Fan, Chief Executive Officer, and Wan Lung Eng, Chief Financial Officer, will provide a live presentation relating to the Company’s interim results via the Investor Meet Company platform on Monday, 13 September at 16:30hrs BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Spectral MD Holdings, Ltd. via:

Investors who already follow Spectral MD Holdings, Ltd. on the Investor Meet Company platform will automatically be invited.

Editor Details

Related Links

Last Updated: 07-Sep-2021